NEW YORK (AP) 鈥� NEW YORK (AP) 鈥� Syndax Pharmaceuticals Inc. (SNDX) on Thursday reported a loss of $42.7 million in its first quarter.
The New York-based company said it had a loss of 48 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.
The biopharmaceutical company posted revenue of $64.9 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $70 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/SNDX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
